Questions. Beyond ELISA: ultrasensitive detection of disease biomarkers via enzyme-guided nanoparticle growth 21 Nov, 2013

Visto 1810 veces

Questions. Beyond ELISA: ultrasensitive detection of disease biomarkers via enzyme-guided nanoparticle growth

The Institute of Biomedical Research of Vigo (IBIV), within BIOCAPS´ Project Framework, has celebrated the “1st International Congress on Biomedical Research & Innovation” on the 21st and 22nd of November 2013 in Vigo, Spain. The event highlights the most important R&D aspects related to the Biomedical Research and Innovation in the following fields: Neurological sciences and rare diseases; Infectious diseases, Inflammation and Immunity; Endocrinology, Metabolism and Nutrition; Biomaterials, Tissue engineering and Regenerative Medicine; New tools in diagnosis and therapy; Ageing and cardiovascular diseases; and Biomedical Innovation. In each field, renowned researchers expose their studies. The congress is expected to become a point of reference for Biomedical Research and Innovation, transmitting scientific perspective and awareness among scientists, public bodies, enterprises and the society.

Roberto de la Rica Quesada
Research Fellow in Stevens' Group, Imperial College London, South Kensington Campus